Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal triamcinolone vs bevacizumab vs combination in central retinal vein occlusion
TCTR20170612005Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial in central retinal vein occlusion (CRVO) comparing Intravitreal triamcinolone, Intravitreal bevacizumab and Intravitreal triamcinolone + bevacizumab (3 arms). Started Feb 2016; status: completed.
02
Drugs
triamcinolonebevacizumab
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on TCTR20170612005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170612005.